An official website of the United States government Here’s how you know

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

In this section: Approved Blood Products

Flebogamma DIF 10%

Proper Name: Immune Globulin Intravenous (Human)
Tradename: Flebogamma DIF 10%
Manufacturer: Instituto Grifols, SA, License #1181
Indication: For the treatment of primary immune deficiency (PI) including the humoral immune defect in common variable immunodeficiency, x-linked agammaglobulinemia, severe combined immunodeficiency, and Wiskott-Aldrich syndrome.

Package Insert

Package Insert - Flebogamma DIF 10%

Supporting Documents

Supporting Documents older than three years - Flebogamma DIF 10%

Top